This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Selinexor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Selinexor Means in Everyday Medical Language

Selinexor is a medicine used to treat certain cancers, including some types of lymphoma and multiple myeloma. It is sold under the brand name Xpovio. This drug works by blocking a protein called CRM1 (also known as exportin 1), which helps cancer cells grow and survive. By stopping this protein, selinexor can slow down or kill cancer cells. It is a type of targeted therapy known as a selective inhibitor of nuclear export.

Why Selinexor Can Matter in Cancer Care

Selinexor is often used when other cancer treatments have not worked or when the cancer has come back after previous therapies. For example, it is approved for adults with diffuse large B-cell lymphoma who have tried at least two other treatments, and for multiple myeloma patients who have received several prior therapies. It offers a new option for people whose cancers are resistant to standard treatments. Because it works differently from many other cancer drugs, it may help when other medicines no longer do.

What Patients Might See or Experience

If your doctor mentions selinexor, you might hear it called Xpovio as well. It is usually taken as a pill, often combined with other drugs like dexamethasone or bortezomib. Common side effects include feeling tired, nausea, vomiting, loss of appetite, diarrhea, and low blood counts such as low platelets or anemia. These side effects can sometimes be managed with supportive care or dose changes. Your care team will monitor you closely during treatment.

Where You Might Encounter the Term Selinexor

You may see selinexor mentioned in your medical records, treatment plans, or lab reports. It can also appear on drug information pages, clinical trial listings, or patient education materials. Because it has several names, including Xpovio and its research code KPT-330, comparing these names can help avoid confusion. If you find the term in any document, it’s important to ask your healthcare provider what it means for your care specifically.

What Selinexor Does Not Automatically Mean

Seeing the name selinexor does not mean you have a certain diagnosis or that this drug is the right treatment for you. It is one option among many and is usually used after other treatments have been tried. It also does not guarantee a cure or specific results. Each person’s situation is unique, so the presence of this drug in your care plan should be discussed with your medical team to understand its role.

Common Questions to Ask Your Care Team

You might want to ask how selinexor works for your type of cancer, what side effects to expect, and how they will be managed. It’s also helpful to ask about how this drug fits with other treatments you have had or may receive. If you see the term in a report or plan, ask what it means for your current care and what to watch for during treatment.

Understanding Selinexor in Context

This information is meant to help you understand what selinexor is and how it might be used in cancer treatment. It is not a recommendation or a complete guide to your care. Always rely on your healthcare team for advice tailored to your health. If you have questions or concerns about selinexor or any treatment, don’t hesitate to discuss them with your doctors or nurses.

Next Steps for Patients and Caregivers

If you come across the term selinexor or Xpovio in your medical care, the best next step is to ask your care team what it means for you personally. They can explain why it might be part of your treatment, what benefits and risks it carries, and how it fits into your overall cancer care plan. Staying informed and asking questions helps you take an active role in your treatment journey.

Sources

Public source information used for this glossary entry includes: